FASN and neoplasm: Furthermore, it suggests FASN activity need not be completely inhibited; instead, novel therapeutics that influence the spectrum of products produced by FASN may be sufficient to alter tumor properties such as signaling pathway activation, cell proliferation, and metastasis.